Please login to the form below

Not currently logged in
Email:
Password:

Flatiron

This page shows the latest Flatiron news and features for those working in and with pharma, biotech and healthcare.

FDA and Flatiron extend real world evidence collaboration

FDA and Flatiron extend real world evidence collaboration

Flatiron's Zach Weinberg. “In order for the entire industry to benefit from RWE, we must ensure that our datasets are comprehensive and of the highest-quality. ... Working with the FDA enables Flatiron to both learn from their leadership and continue

Latest news

  • Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

    The news is eye-catching as it is the first after Roche completed its $1.9bn acquisition of Flatiron last month. ... Roche and Flatiron had stipulated that the buyout would not see Flatiron turning away new pharma partnerships.

  • Digital shakeout Digital shakeout

    Two successes and two failures provide interesting contrasts. The first good news is Flatiron’s acquisition by Roche, which reveals how using real-time big data is transforming oncology.

  • Roche to buy cancer data firm Flatiron for $1.9bn Roche to buy cancer data firm Flatiron for $1.9bn

    Data provides a wealth of RWE opportunities. Swiss pharma group Roche has beefed up its big data capabilities with a deal to buy Flatiron Health, which focuses on cancer data and ... Software developed by Flatiron - which is backed by Google parent

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics